Invasive breast carcinoma – Life with Disease

Go back

Invasive breast carcinoma is the most common form of breast cancer, occurring when abnormal cells break through the walls of milk ducts or milk-producing glands and spread into surrounding breast tissue. While this diagnosis can be frightening, understanding what it means and what options exist can help you navigate your journey with greater confidence and hope.

Prognosis and Life Expectancy

When you receive a diagnosis of invasive breast carcinoma, one of the first questions that naturally comes to mind is about your future. It’s important to know that prognosis varies greatly from person to person, and many factors influence how the disease will progress and respond to treatment. The outlook depends on several key elements, including the size of the tumor when discovered, whether cancer cells have reached nearby lymph nodes, the specific type of invasive cancer, and how abnormal the cells appear under a microscope, which doctors call the grade.[2]

Today, many people with invasive breast carcinoma are living longer and healthier lives than ever before. This is largely because of advances in early detection through mammography and improvements in treatment options. When invasive breast cancer is detected early, before it has spread to distant parts of the body, healthcare providers often have the opportunity to provide treatments that can be curative. Women age 55 and older are most commonly affected by this condition, though it can occur in younger women as well.[10]

Invasive ductal carcinoma, which starts in the milk ducts and accounts for about 70 to 80 percent of all invasive breast cancers, represents the most frequent type. Invasive lobular carcinoma, beginning in the milk-producing glands, is the second most common type, making up about 10 to 15 percent of cases.[9] The survival outlook for both types has improved significantly as medical science has developed better understanding of how these cancers behave and which treatments work best.

Your individual prognosis also depends on the biological features of your cancer. Doctors test cancer cells to see if they have receptors for hormones like estrogen and progesterone, and whether they produce high levels of a protein called HER2. These features, called receptor status, help predict how the cancer might grow and which treatments will be most effective. Cancers that have hormone receptors or produce HER2 protein often respond well to targeted therapies designed specifically for those characteristics.[15]

⚠️ Important
Statistical survival rates published in studies often reflect patients treated several years ago, before many recent treatment advances became available. Because research data can be two or more years behind current practice, and because survival studies look back five or more years, you may actually have a better outlook than older statistics suggest. New treatments, including advanced targeted therapies and better testing methods, continue to improve outcomes for people diagnosed today.

Natural Progression Without Treatment

Understanding how invasive breast carcinoma develops and progresses when left untreated helps explain why early detection and treatment are so important. The term “invasive” means that cancer cells have broken through the walls of the ducts or lobules where they originated and moved into the surrounding fatty and connective tissue of the breast. This is different from a condition called ductal carcinoma in situ, or DCIS, where abnormal cells remain contained within the duct walls.[2]

Once cancer cells become invasive, they gain the ability to travel beyond the breast. They can move through the body in two main ways: through blood vessels or through the lymphatic system, which is a network of vessels and small bean-shaped structures called lymph nodes that help fight infection. The lymph nodes in the armpit area, called axillary lymph nodes, are usually the first place breast cancer spreads if it moves beyond the breast tissue itself.[5]

Without treatment, invasive breast carcinoma typically continues to grow. The tumor in the breast may increase in size, becoming more noticeable as a lump or causing changes in the breast’s appearance. You might notice the skin becoming dimpled or puckered, similar to the texture of an orange peel. The nipple might turn inward or produce unusual discharge. The breast may change in size, shape, or feel. As the tumor grows larger, it becomes more likely that cancer cells will spread to lymph nodes and eventually to other organs in the body.[2]

The speed at which invasive breast carcinoma progresses varies considerably. Some cancers grow slowly over months or years, while others can grow more aggressively. The tumor’s grade, which describes how abnormal the cells look under a microscope and how quickly they’re dividing, gives doctors clues about how fast the cancer might progress. Higher-grade tumors tend to grow and spread more quickly than lower-grade ones.[8]

Possible Complications

Invasive breast carcinoma can lead to several complications, both from the disease itself and as it advances. The most serious complication is metastasis, which occurs when cancer cells spread from the breast to other parts of the body. When breast cancer metastasizes, it most commonly travels to the bones, lungs, liver, or brain. This advanced stage, called stage IV or metastatic breast cancer, represents the most serious form of the disease and requires different treatment approaches than earlier stages.[5]

In the breast itself, growing tumors can cause physical discomfort and noticeable changes. Large tumors may distort the breast’s shape or cause a marble-like hardened area under the skin. The skin over the tumor may become inflamed, red, or develop an unusual texture. In rare cases, cancer cells can block lymph vessels in the breast skin, leading to a fast-growing type called inflammatory breast cancer, which makes the breast appear swollen, warm, and red.[9]

When cancer spreads to lymph nodes in the armpit, it can cause swelling in that area and potentially lead to a condition called lymphedema. Lymphedema is persistent swelling that occurs when lymph fluid cannot drain properly, often affecting the arm on the side where lymph nodes were affected or removed during treatment. This swelling can be uncomfortable and may require ongoing management.[2]

Another concern is the possibility of cancer recurrence. Even after successful initial treatment, there’s a risk that cancer cells may return either in the breast area (called local recurrence) or in other parts of the body (distant recurrence). The risk of recurrence depends on many factors, including the original tumor’s size, grade, receptor status, and whether cancer had reached the lymph nodes when first diagnosed.[2]

Impact on Daily Life

Living with invasive breast carcinoma affects more than just physical health. The diagnosis and treatment process touches nearly every aspect of daily life, from work and family responsibilities to emotional well-being and future planning. Understanding these impacts can help you prepare for the journey ahead and develop strategies for maintaining quality of life throughout treatment.

Physically, both the cancer itself and its treatments can affect your energy levels and ability to perform everyday tasks. Many people experience fatigue that goes beyond ordinary tiredness, making it difficult to complete normal activities or maintain their usual work schedule. Treatments like chemotherapy, radiation, and surgery each bring their own set of side effects. Chemotherapy may cause nausea, hair loss, and increased susceptibility to infections. Radiation can lead to skin irritation and tiredness. Surgery requires recovery time and may temporarily limit arm movement, especially if lymph nodes were removed.[2]

Emotionally, a breast cancer diagnosis often triggers a complex mix of feelings. Fear about the future, anxiety about treatment, sadness, and anger are all normal responses. Some people experience periods of feeling overwhelmed or struggle with depression. The uncertainty about what lies ahead and concerns about how the disease might affect loved ones add to the emotional burden. It’s common to feel confused or disoriented initially, and these feelings may persist as you adjust to your new reality.[18]

Social relationships and family dynamics often shift during treatment. You may need to rely on others for help with tasks you usually manage independently, such as driving to appointments, preparing meals, or caring for children. Some people find it difficult to discuss their diagnosis with friends or family members, while others struggle with well-meaning but unwelcome advice. Intimate relationships and body image concerns, particularly after surgery, can affect emotional and physical intimacy with partners.[18]

Work life frequently requires adjustments. Depending on your treatment schedule and how you feel, you might need to reduce your hours, take leave, or make special arrangements with your employer. Financial concerns often arise from medical expenses, even with insurance, combined with potential loss of income. Managing healthcare costs, insurance paperwork, and understanding coverage options becomes an additional responsibility during an already stressful time.[22]

Finding ways to cope with these challenges is essential for maintaining well-being. Many people benefit from connecting with others who have faced similar experiences, either through support groups or online communities. Taking care of your emotional health through counseling, meditation, or other stress-reduction techniques can help. Staying as physically active as your condition allows often improves both physical and mental well-being. Focusing on the aspects of life that bring meaning and joy, even during treatment, helps maintain a sense of purpose and hope.[21]

Support for Families and Participating in Clinical Trials

Family members and close friends play a crucial role in supporting someone diagnosed with invasive breast carcinoma, especially when considering participation in clinical trials. Understanding what clinical trials involve and how to help a loved one explore these options can make a significant difference in their treatment journey and contribute to advancing medical knowledge that helps future patients.

Clinical trials are research studies that test new treatments, diagnostic approaches, or prevention strategies for breast cancer. While standard treatments have been proven effective through previous research, clinical trials offer access to newer therapies that might not yet be widely available. Some trials compare existing treatments in new combinations or test whether lower doses or shorter treatment durations can be equally effective with fewer side effects.[15]

When someone you care about is diagnosed with invasive breast carcinoma, learning about clinical trials together can be empowering. Family members can help by researching trial options, accompanying their loved one to appointments where trials are discussed, and helping evaluate whether a particular trial aligns with their treatment goals and personal preferences. It’s important to understand that participating in a clinical trial is always voluntary, and patients can withdraw at any time without affecting their standard care.

Helping your loved one prepare for clinical trial discussions involves practical steps. You can assist by organizing medical records, creating lists of questions to ask the research team, and taking notes during consultations. Important questions include understanding the trial’s purpose, what treatments or procedures it involves, potential benefits and risks, how it compares to standard treatment, and what time commitments are required. Family members often serve as a second set of ears during these complex discussions, helping remember important details when emotions run high.[22]

Supporting someone through the decision-making process about clinical trials requires patience and respect for their autonomy. Some people feel excited about contributing to research that might help others, while others prefer proven treatments. Both choices are valid. Your role is to provide emotional support, help gather information, and respect whatever decision they make. Avoid pushing your own preferences; instead, help them think through their options and priorities.

Beyond clinical trials, families can support their loved ones in many practical ways throughout the cancer journey. Accompanying them to medical appointments provides emotional comfort and ensures important information isn’t missed. Helping manage the logistics of treatment—scheduling appointments, arranging transportation, organizing medications—reduces the burden on the patient. Assisting with household tasks, meal preparation, and childcare during recovery periods allows them to focus on healing. Simply being present, listening without trying to fix everything, and allowing them to express difficult emotions without judgment provides invaluable emotional support.[18]

⚠️ Important
Taking care of yourself as a caregiver or family member is not selfish—it’s essential. Supporting someone with cancer is emotionally and physically demanding. Make sure you’re getting adequate rest, maintaining your own health appointments, and seeking support for yourself when needed. Many cancer centers offer support groups specifically for family members and caregivers. Remember that you can’t pour from an empty cup; maintaining your own well-being enables you to better support your loved one.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • CDK 4/6 inhibitors – Target specific points in growth signaling pathways for hormone receptor-positive metastatic breast cancer
  • PIK3CA inhibitors – Used for treatment of estrogen receptor-positive metastatic breast cancer by targeting specific growth pathways
  • mTOR inhibitors – Target growth signaling pathways in hormone receptor-positive metastatic breast cancer
  • AKT inhibitors – Used for hormone receptor-positive metastatic breast cancer to block specific growth signals
  • Elacestrant (Orserdu) – An oral selective estrogen receptor degrader (SERD) for hormone receptor-positive cancer
  • Trastuzumab deruxtecan (Enhertu) – An antibody-drug conjugate for HER2-positive and triple-negative metastatic breast cancer
  • Sacituzumab govitecan (Trodelvy) – An antibody-drug conjugate for triple-negative metastatic breast cancer
  • Pertuzumab (Perjeta) – Targeted therapy for HER2-positive metastatic breast cancer
  • Ado-trastuzumab emtansine (Kadcyla) – Targeted therapy for HER2-positive metastatic breast cancer
  • Tucatinib (Tukysa) – Targeted therapy for HER2-positive metastatic breast cancer
  • PARP inhibitors – For BRCA1 and BRCA2 mutation-positive metastatic breast cancer
  • Denosumab (Prolia) – Used for advanced breast cancer patients with bone metastases
  • Zoledronic acid (Reclast) – Bisphosphonate for treating bone metastases in advanced breast cancer
  • Pamidronate (Aredia) – Bisphosphonate for treating bone metastases in advanced breast cancer

Ongoing Clinical Trials on Invasive breast carcinoma

  • Study on Indocyanine Green for Evaluating Surgical Margins in Patients Undergoing Breast-Conserving Surgery for Early Invasive Breast Cancer

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium
  • A study testing zanidatamab combined with chemotherapy before surgery in patients with HER2-positive breast cancer

    Not yet recruiting

    1 1 1
    Germany Italy Spain

References

https://www.cancer.org/cancer/types/breast-cancer/about/types-of-breast-cancer/invasive-breast-cancer.html

https://www.cancerresearchuk.org/about-cancer/breast-cancer/types/invasive-breast-cancer

https://breastcancernow.org/about-breast-cancer/diagnosis/types-of-breast-cancer/invasive-breast-cancer-no-special-type

https://www.bcrf.org/about-breast-cancer/invasive-ductal-carcinoma/

https://www.komen.org/breast-cancer/facts-statistics/what-is-breast-cancer/invasive-breast-cancer/

https://www.mdanderson.org/cancerwise/invasive-ductal-carcinoma–6-things-to-know-about-this-common-breast-cancer.h00-159775656.html

https://www.nationalbreastcancer.org/invasive-ductal-carcinoma/

https://www.webmd.com/breast-cancer/invasive-breast-cancer

https://www.cdc.gov/breast-cancer/about/index.html

https://my.clevelandclinic.org/health/diseases/22117-invasive-ductal-carcinoma-idc

https://www.nationalbreastcancer.org/invasive-ductal-carcinoma/

https://www.ncbi.nlm.nih.gov/books/NBK6879/

https://www.cancerresearchuk.org/about-cancer/breast-cancer/types/invasive-breast-cancer

https://www.cedars-sinai.org/health-library/diseases-and-conditions/i/invasive-ductal-breast-cancer-idc.html

https://www.aafp.org/pubs/afp/issues/2021/0800/p171.html

https://www.cancer.gov/types/breast/patient/breast-treatment-pdq

https://www.mdanderson.org/cancerwise/invasive-ductal-carcinoma–6-things-to-know-about-this-common-breast-cancer.h00-159775656.html

https://www.breastcancer.org/types/metastatic/life-with-metastatic/tips-for-moving-forward

https://www.mayoclinic.org/healthy-lifestyle/womens-health/in-depth/breast-cancer-prevention/art-20044676

https://www.nationalbreastcancer.org/invasive-ductal-carcinoma/

https://www.lbbc.org/your-journey/living-with-metastatic-breast-cancer/living-well-with-metastatic-breast-cancer

https://www.premiersurgicalnetwork.com/blog/navigating-life-after-breast-cancer-diagnosis?utm_source=loclisting&utm_medium=Organic&utm_campaign=directory-appt&utm_content=PSNPA&rsiCampaignId=43255

https://www.bcrf.org/about-breast-cancer/breast-cancer-prevention-risk-reduction/

https://www.komen.org/blog/four-tips-for-living-well-with-metastatic-breast-cancer/

https://my.clevelandclinic.org/health/diseases/3986-breast-cancer

FAQ

What’s the difference between invasive ductal carcinoma and ductal carcinoma in situ?

Ductal carcinoma in situ (DCIS) means abnormal cells are contained entirely within the milk ducts and haven’t broken through to surrounding tissue. Invasive ductal carcinoma means cancer cells have broken through the duct walls into the surrounding breast tissue. DCIS is considered a pre-invasive condition, while invasive cancer has the potential to spread to lymph nodes and other parts of the body.

Can invasive breast cancer be cured?

When invasive breast cancer is detected early, before it spreads to distant parts of the body, healthcare providers can often cure it with appropriate treatment. The cure rate depends on many factors including the stage at diagnosis, tumor characteristics, and how well the cancer responds to treatment. Even at more advanced stages, many people live for years with good quality of life, though metastatic breast cancer is generally considered treatable but not curable.

How quickly does invasive breast carcinoma spread?

The speed at which invasive breast carcinoma grows and spreads varies considerably between individuals. Some cancers grow slowly over months or years, while others are more aggressive. The tumor grade, which indicates how abnormal the cells look and how quickly they’re dividing, provides clues about growth speed. Higher-grade tumors typically grow and spread faster than lower-grade ones.

Why do doctors need to know my cancer’s receptor status?

Your cancer’s receptor status tells doctors whether the cancer cells have receptors for hormones like estrogen and progesterone, and whether they produce high levels of HER2 protein. This information is crucial because it helps predict how your cancer might grow and which treatments will be most effective. Cancers with hormone receptors can often be treated with hormone-blocking therapies, while HER2-positive cancers respond to targeted treatments designed specifically for that protein.

What are the chances of invasive breast cancer coming back after treatment?

The risk of recurrence depends on many factors including the original tumor’s size, grade, receptor status, and whether cancer had reached lymph nodes at diagnosis. Recurrence can happen either in the breast area (local recurrence) or in other parts of the body (distant recurrence). Your healthcare team can discuss your individual risk based on your specific cancer characteristics and provide strategies to reduce that risk through ongoing treatment and monitoring.

🎯 Key takeaways

  • Invasive breast carcinoma affects 70-80% of breast cancer patients, making it the most common type, yet today’s treatments offer better outcomes than ever before
  • Early detection through mammography can find cancers before symptoms appear, significantly improving treatment success rates
  • Your cancer’s receptor status—whether it responds to estrogen, progesterone, or HER2—determines which targeted treatments will work best for you
  • Recent treatment advances including antibody-drug conjugates and molecular biomarker testing mean current survival rates are likely better than published statistics from several years ago
  • Invasive lobular carcinoma may not form a distinct lump, appearing instead as thickened tissue that’s harder to detect on mammograms
  • Family members play a vital role in supporting treatment decisions, including helping evaluate clinical trial opportunities
  • Maintaining emotional and physical well-being through support groups, exercise, and stress reduction improves quality of life during treatment
  • The lymph nodes in your armpit are usually the first place breast cancer spreads if it moves beyond the breast, which is why doctors check them carefully